Medical Equipment

Global Tuberculosis Diagnostics Market Revenue and Share Analysis Through 2029

December 4, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the tuberculosis diagnostics market from 2025–2034 with trusted insights from The Business Research Company

What Is The Projected Valuation Of The Tuberculosis Diagnostics Market In The Period 2029-2034?

The tuberculosis diagnostics market size has exhibited robust growth over recent years. It is projected to increase from $2.21 billion in 2024 to $2.34 billion in 2025, achieving a compound annual growth rate (CAGR) of 5.9%. The expansion observed historically can be attributed to factors such as the rising incidence of tuberculosis, greater healthcare expenditure, an increase in the number of healthcare facilities, and the growing adoption of nucleic acid testing.

The tuberculosis diagnostics market is projected to experience robust expansion over the coming years, reaching $3.15 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 7.7%. This anticipated growth during the forecast period can be primarily attributed to several factors, including significant government backing, a rise in FDA approvals for tuberculosis diagnostics, escalating research and development (R&D) endeavors, and the increasing prevalence of drug-resistant TB. Key trends during this period are anticipated to encompass a heightened emphasis on next-generation sequencing (NGS) platforms for TB diagnostics, advancements in product innovation, the adoption of t-cell tests for TB infection, the development of artificial intelligence (AI)-based tuberculosis diagnostics, the widespread use of portable devices, and stronger collaborations between governmental bodies and manufacturers.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8165&type=smp

What Strategic Drivers Are Accelerating The Tuberculosis Diagnostics Market Expansion?

The increasing occurrence of tuberculosis is fueling the demand for the tuberculosis diagnostics market moving forward. Tuberculosis is an infectious disease that primarily impacts the lungs and can be quite serious. It spreads through coughing and sneezing, which releases minute germs into the air. Tuberculosis diagnostics are instrumental in patient detection, allowing for earlier diagnosis and identification of diseases. As an illustration, in March 2023, the Centers for Disease Control and Prevention, a US-based national public health organization, reported that in the United States, 8,300 cases of tuberculosis (TB) were recorded in 2022, marking a rise from 7,874 cases in 2021. Consequently, the escalating incidence of tuberculosis is driving the tuberculosis diagnostics market. Therefore, the continued rise in tuberculosis cases is propelling the growth of the tuberculosis diagnostics market.

What Is The Detailed Segment Distribution Of The Tuberculosis Diagnostics Market?

The tuberculosis diagnosticsmarket covered in this report is segmented –

1) By Test Type: Radiographic Tests, Nucleic Acid Testing, Cytokine Detection Tests, Drug Resistance Tests, Skin Test / Mantoux Test (TST), Blood/Serology Test, Smear Microscopy Tests, Cell Culture-Based Tests, Other Test Types

2) By Disease Stage: Latent Tuberculosis, Active Tuberculosis

3) By End-User: Hospitals And Diagnostic Laboratories, Physician’s Office Laboratories, Reference Laboratories, Academics And Research Facilities

Subsegments:

1) By Radiographic Tests: Chest X-rays, CT Scans

2) By Nucleic Acid Testing: Polymerase Chain Reaction (PCR), Nucleic Acid Amplification Tests (NAATs)

3) By Cytokine Detection Tests: Interferon Gamma Release Assays (IGRAs)

4) By Drug Resistance Tests: GeneXpert MTB/RIF, Line Probe Assays

5) By Skin Test or Mantoux Test (TST): Tuberculin Skin Test (TST)

6) By Blood Or Serology Test: Serological Tests for Antibodies

7) By Smear Microscopy Tests: Acid-Fast Bacilli (AFB) Smear Test

8) By Cell Culture-Based Tests: Solid Media Cultures, Liquid Media Cultures

9) By Other Test Types: Molecular Tests, Advanced Imaging Techniques

How Are Global Trends Impacting The Development Of The Tuberculosis Diagnostics Market?

A prominent trend gaining traction within the tuberculosis diagnostics market is the adoption of technological advancements. Leading firms active in this market are rolling out novel technologies, including sophisticated point-of-care (POC) diagnostic techniques leveraging AI technology, to maintain their competitive standing. As an illustration, in August 2022, Fujifilm, a Japanese manufacturer of medical imaging devices, collaborated with Qure.ai, a US-based developer of AI-powered medical imaging solutions, to introduce an enhanced point-of-care (POC) diagnostic approach. This method employs a battery-operated X-ray machine specifically for diagnosing tuberculosis. Artificial intelligence-driven algorithms support effective testing programs, providing extreme portability, precise accuracy, and streamlined point-of-care diagnostic solutions.

Who Are The Major Stakeholders Operating In The Tuberculosis Diagnostics Market?

Major companies operating in the tuberculosis diagnostics market include Beckton, Dickinson and Company, F. Hoffmann-La Roche Ltd, Qiagen N.V, BioMerieux SA, Danaher Corporation, PerkinElmer, Thermo Fisher Scientific Inc., Creative Diagnostics, Lionex GmbH, Biocartis, Bio-Techne India Private Limited, Bio-Rad laboratories India Pvt.Ltd, Zhejiang Di’an Diagnostics Technology Co., Ltd, ADICON Clinical Laboratories, Guangzhou Kingmed Diagnostics Center Co. Ltd., Kindstar Global, OriGene Technologies, Siemens AG, LumiraDx Limited, TestLine Clinical Diagnostics s.r.o., Hologic, Bayer AG, Meridian Bioscience, Abbott laboratories Immunodiagnostic Systems Holdings PLC, Mesa Biotech Inc, Agilent technologies Inc, Akonni Biosystems Inc, Epistem Limited, Gen-Probe, Sysmex South Africa (Pty) Ltd., Bio Certica, BixBio

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/tuberculosis-diagnostics-global-market-report

Which Region Is Projected To Achieve The Fastest Growth In The Tuberculosis Diagnostics Market?

Asia-Pacific was the largest region in the tuberculosis diagnostics market in 2024. The regions covered in the tuberculosis diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=8165&type=smp

Browse Through More Reports Similar to the Global Tuberculosis Diagnostics Market 2025, By The Business Research Company

Respiratory Disposables Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/respiratory-disposables-global-market-report

Respiratory Devices And Equipment Therapeutic Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/respiratory-devices-and-equipment-therapeutic-global-market-report

Respiratory Devices And Equipment Therapeutic And Diagnostic Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/respiratory-devices-and-equipment-therapeutic-and-diagnostic-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795